The β-catenin transcription factor complex consists of several components, including B-cell lymphoma 9 (BCL9) and BCL9-like (BCL9L; refs. 48, 49), whose deletion in mouse tumor models abrogates β-catenin–mediated transcription (14, 50). This evidence concerns the gene BCL9L and neoplasm.